| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/06/2005 | CN1602880A Method for inhibitting bone resorption |
| 04/06/2005 | CN1602879A Method for inhibitting bone resorption |
| 04/06/2005 | CN1602877A Pharmaceutical composition for treating somatization disorder and its preparation process |
| 04/06/2005 | CN1602876A Dimethoxanate hydrochloride dripping pills and its preparation method |
| 04/06/2005 | CN1602875A MolsidominE dripping pills and its preparation process |
| 04/06/2005 | CN1602874A Sustained release preparation of propylthiouracil and its preparation method |
| 04/06/2005 | CN1602873A Sustained release preparation of glipizide/metformin hydrochloride and its preparation method |
| 04/06/2005 | CN1602871A Preparation process of antifungal itraconazole containing freeze dried powder injection and transfusion |
| 04/06/2005 | CN1602870A Dripping pills of bucinnazine hydrochloride and its preparation |
| 04/06/2005 | CN1602869A Dripping pills of eprazinone hydrochloride and its preparation |
| 04/06/2005 | CN1602868A Dripping pills of ketotifen fumarate and its preparation method |
| 04/06/2005 | CN1602867A Soft capsule preparation of donepezi hydrochloride and its preparation method |
| 04/06/2005 | CN1602866A Dripping pills of tripelennamine hydrochloride and its preparation method |
| 04/06/2005 | CN1602865A Fat emulsion injection of bulleyaconitine A and its manufacturing method |
| 04/06/2005 | CN1602864A Vaginal effervescent tablet of fibrauretine and its preparation method |
| 04/06/2005 | CN1602863A Dripping pills of furazabol and its preparation method |
| 04/06/2005 | CN1602861A Buccal tablet for treating oral anaerobe infection disease and its manufacturing method |
| 04/06/2005 | CN1602860A Dripping pills of clemastine fumarate and its preparation method |
| 04/06/2005 | CN1602859A Dripping pills of methoxsalen and its preparation method |
| 04/06/2005 | CN1602857A Orally disintegrating tablet of safflor yellow and its preparation process |
| 04/06/2005 | CN1602854A Taxel preparation for intravenous injection |
| 04/06/2005 | CN1602852A Sodium houttuyfonate injection and its preparation method |
| 04/06/2005 | CN1602851A Dripping pills of benactyzine hydrochloride and its preparation |
| 04/06/2005 | CN1602850A Nú¿2ú®-L-alanyl-L-glutamine injection and its preparation method |
| 04/06/2005 | CN1602849A Propranolol hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1602848A Ambroxol hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1602847A Bupicomide hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1602846A Oxyfenamate hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1602845A Fenfluramine hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1602844A Mitoxantrone or mitoxantrone hydrochloride liposome injection and its preparing process |
| 04/06/2005 | CN1602843A Traditional Chinese medicine sublingual tablets and its preparation method |
| 04/06/2005 | CN1602842A Pharmaceutical aerosol production method and its product |
| 04/06/2005 | CN1602841A Immuno-modulatory agents administration form for whole body or local immunity disorder |
| 04/06/2005 | CN1602835A Aerosol cosmetic composition |
| 04/06/2005 | CN1602758A Nutritious liquor (drink) for relieving the effect of alcohol, alcohol relieving capsule production method |
| 04/06/2005 | CN1602709A Effervescent milk tablet |
| 04/06/2005 | CN1195788C Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| 04/06/2005 | CN1195550C External preparation |
| 04/06/2005 | CN1195549C Stable amorphous amifostine compositions and methods for the preparation and use of same |
| 04/06/2005 | CN1195548C Stable mitoxantron solutions |
| 04/06/2005 | CN1195547C Preventives / remedies for glaucoma |
| 04/06/2005 | CN1195545C Vaginal suppository vaccine for urogenital infections |
| 04/06/2005 | CN1195543C Method for administering monomeric insulin analogs |
| 04/06/2005 | CN1195537C External-applied Chinese medicine for treating hypertension and its preparing process |
| 04/06/2005 | CN1195536C Superfine gastrodia tuber and American ginseng superfine powder buccal lozenge |
| 04/06/2005 | CN1195523C Topical compositions for prostaglandin E1 delivery |
| 04/06/2005 | CN1195518C Sustained release tablet formulations to treat Parkinson disease |
| 04/06/2005 | CN1195511C The use of fumaric acid derivatives in transplant medicine |
| 04/06/2005 | CN1195510C Semisolid pharmaceutical formulation containing dexketoprofen trometamol |
| 04/06/2005 | CN1195509C Aminoethanesulfonic acid-containing preparations |
| 04/06/2005 | CN1195507C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 G/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof |
| 04/06/2005 | CN1195506C Transdermal therapeutic system with improved stability and method for production thereof |
| 04/06/2005 | CN1195505C Microreservoir system on basis of polysiloxanes and ambiphilic solvents |
| 04/06/2005 | CN1195504C Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 04/06/2005 | CN1195503C Transdermal patch and topical compositions comprising propylnorapomorphine |
| 04/06/2005 | CN1195502C Periadventitial delivery device |
| 04/06/2005 | CN1195501C Transdermal therapeutic system (TTS) for administrating sexual steroid hormones |
| 04/06/2005 | CN1195500C Orally disintegrable tablet |
| 04/06/2005 | CN1195499C Enteric coated pharmaceutical tablet and method of manufacturing |
| 04/06/2005 | CN1195498C Directly compressed solid dosage particles |
| 04/06/2005 | CN1195497C Biodegradable polymer encapsulated 5-hydroxytryptamine receptor antagonist and method for preparing the same |
| 04/06/2005 | CN1195496C Controlled release formulation for treating COPD |
| 04/06/2005 | CN1195495C Emulsion preconcentrate containing cyclosporin or macrolide |
| 04/06/2005 | CN1195494C Oral liquid mucoadhesive compositions |
| 04/06/2005 | CN1195493C Absorbable silicon implants containing beneficial substance |
| 04/06/2005 | CN1195415C Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| 04/05/2005 | US6875793 Once-a-day controlled release sulfonylurea formulation |
| 04/05/2005 | US6875749 Methods of facilitating vascular growth |
| 04/05/2005 | US6875748 Sodium and potassium phosphate salts, in aqueous solution, and detergents and surfactants for direct polypeptide delivery into vertebrate cells |
| 04/05/2005 | US6875453 Non-toxic disinfectant containing a isopropyl alcohol and sesame oil composition with lemon oil and menthol |
| 04/05/2005 | US6875451 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 04/05/2005 | US6875449 Crystal structure |
| 04/05/2005 | US6875448 Method of intracellular sustained-release of drug and preparations |
| 04/05/2005 | US6875447 Analgesics; pain therapy; administering by injection |
| 04/05/2005 | US6875446 Method for prophylaxis and/or treatment of thromboembolism |
| 04/05/2005 | US6875443 An alcohol with chain length from about c20-c36 including policosanol, are therapeutically useful materials with efficacy in lowering cholesterol, can be advantageously added to foods such as margarines and salad dressings |
| 04/05/2005 | US6875441 Composition for delivery of hematopoietic growth factor |
| 04/05/2005 | US6875432 Reduced-viscosity concentrated protein formulations |
| 04/05/2005 | US6875431 Therapy of bacterial infections by the use of a lysing enzyme blended with an appropriate carrier |
| 04/05/2005 | US6875208 Microchip devices with improved reservoir opening |
| 04/05/2005 | CA2203540C Major outer membrane protein cd of moraxella |
| 04/05/2005 | CA2171435C Effervescent granulated material and method for its preparation |
| 04/05/2005 | CA2162280C Use of a polymer material on the basis of modified hydrocolloids as a coating, covering wall material |
| 04/05/2005 | CA2081283C Substrate material for smoking articles |
| 03/31/2005 | WO2005028032A1 Injectable therapeutic formulations |
| 03/31/2005 | WO2005028018A1 Fluid medication delivery device |
| 03/31/2005 | WO2005027996A2 Application of a therapeutic substance to a tissue location using an expandable medical device |
| 03/31/2005 | WO2005027989A1 Disinfectant, antibiotic and anesthetic containing device for injections and incisions |
| 03/31/2005 | WO2005027979A2 Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells |
| 03/31/2005 | WO2005027976A2 Composition comprising ether lipid |
| 03/31/2005 | WO2005027960A1 Liquid human growth hormone formulation containing polyethylene glycol |
| 03/31/2005 | WO2005027955A1 Oral compositions for the stimulation of gastric acid secretion comprising pentagastrin |
| 03/31/2005 | WO2005027952A1 Composition exerting physiological activity via biological immune mechanism |
| 03/31/2005 | WO2005027949A1 Turmeric-containing composition |
| 03/31/2005 | WO2005027948A1 Powdery composition for use as a laxative |
| 03/31/2005 | WO2005027945A1 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same |
| 03/31/2005 | WO2005027940A1 Cataplasm for repairing damaged skin |
| 03/31/2005 | WO2005027939A1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| 03/31/2005 | WO2005027932A1 5-aminosalicylic acid solid preparation improved in discoloration and method of storing the same |
| 03/31/2005 | WO2005027906A1 Transscleral delivery |